Capital International Increased By $567,000 Its Astrazeneca Plc Adr (AZN) Stake; Vuzix (VUZI) Had 4 Analysts Last Week

May 29, 2017 - By Linda Rogers

Among 4 analysts covering Vuzix (NASDAQ:VUZI), 4 have Buy rating, 0 Sell and 0 Hold. Therefore 100% are positive. Vuzix had 7 analyst reports since August 17, 2015 according to SRatingsIntel. The rating was reinitiated by Chardan Capital Markets on Monday, September 28 with “Buy”. Zacks downgraded the stock to “Hold” rating in Friday, August 21 report. The firm has “Buy” rating by Rodman & Renshaw given on Thursday, December 10. The firm has “Buy” rating given on Monday, August 17 by Chardan Capital Markets. The firm has “Buy” rating by Maxim Group given on Friday, October 28. The stock of Vuzix Corporation (NASDAQ:VUZI) has “Buy” rating given on Monday, December 14 by Chardan Capital Markets. The stock has “Buy” rating by H.C. Wainwright on Thursday, December 10. See Vuzix Corporation (NASDAQ:VUZI) latest ratings:

Capital International Inc increased Astrazeneca Plc Adr (AZN) stake by 134.62% reported in 2016Q4 SEC filing. Capital International Inc acquired 21,000 shares as Astrazeneca Plc Adr (AZN)’s stock rose 16.26%. The Capital International Inc holds 36,600 shares with $1.00M value, up from 15,600 last quarter. Astrazeneca Plc Adr now has $84.38B valuation. The stock decreased 1.40% or $0.48 on May 26, reaching $33.85. About 2.56M shares traded. AstraZeneca plc (ADR) (NYSE:AZN) has risen 19.45% since May 29, 2016 and is uptrending. It has outperformed by 2.75% the S&P500.

Since January 20, 2017, it had 2 insider buys, and 0 sales for $20,194 activity. The insider Travers Paul J bought $2,181.

It closed at $5.8 lastly. It is down 11.43% since May 29, 2016 and is uptrending. It has underperformed by 5.27% the S&P500.

Investors sentiment decreased to 1.82 in 2016 Q4. Its down 0.56, from 2.38 in 2016Q3. It worsened, as 7 investors sold Vuzix Corporation shares while 4 reduced holdings. 10 funds opened positions while 10 raised stakes. 2.29 million shares or 59.52% more from 1.43 million shares in 2016Q3 were reported. One Trading L P accumulated 45,992 shares. Carl Domino reported 12,000 shares or 0.09% of all its holdings. Oz Ltd Partnership reported 0% of its portfolio in Vuzix Corporation (NASDAQ:VUZI). Northern Tru Corp invested in 24,839 shares. Price T Rowe Associate Inc Md has invested 0% in Vuzix Corporation (NASDAQ:VUZI). Blackrock Institutional Trust Na has invested 0% of its portfolio in Vuzix Corporation (NASDAQ:VUZI). Peak6 Limited Partnership has 30,421 shares. The California-based Blackrock Fund has invested 0% in Vuzix Corporation (NASDAQ:VUZI). Comml Bank Of Montreal Can invested 0% of its portfolio in Vuzix Corporation (NASDAQ:VUZI). First Eagle Invest Management Ltd Com holds 25,000 shares. Lba Wealth Mgmt Limited Com has invested 0% in Vuzix Corporation (NASDAQ:VUZI). Vanguard Group invested in 523,518 shares. Da Davidson &, a Montana-based fund reported 500 shares. 100 were reported by Macroview. Royal Comml Bank Of Canada has invested 0% of its portfolio in Vuzix Corporation (NASDAQ:VUZI).

Among 19 analysts covering AstraZeneca plc (ADR) (NYSE:AZN), 12 have Buy rating, 0 Sell and 7 Hold. Therefore 63% are positive. AstraZeneca plc (ADR) had 25 analyst reports since July 31, 2015 according to SRatingsIntel. The rating was downgraded by HBSC on Monday, February 8 to “Hold”. Argus Research upgraded the shares of AZN in report on Monday, August 29 to “Buy” rating. The firm earned “Hold” rating on Monday, April 10 by Jefferies. The stock of AstraZeneca plc (ADR) (NYSE:AZN) earned “Equal-Weight” rating by Barclays Capital on Tuesday, January 19. The company was downgraded on Wednesday, September 14 by BNP Paribas. The firm has “Buy” rating given on Monday, September 14 by Deutsche Bank. The stock has “Overweight” rating by Piperjaffray on Friday, September 23. S&P Research upgraded the stock to “Buy” rating in Friday, July 31 report. Cantor Fitzgerald initiated AstraZeneca plc (ADR) (NYSE:AZN) on Friday, February 26 with “Buy” rating. The stock of AstraZeneca plc (ADR) (NYSE:AZN) earned “Neutral” rating by Credit Suisse on Friday, May 12.

Capital International Inc decreased Netapp Inc (NASDAQ:NTAP) stake by 16,400 shares to 4,800 valued at $169,000 in 2016Q4. It also reduced Banco Bradesco Sa Pn Adr (NYSE:BBD) stake by 1.24M shares and now owns 2.36 million shares. Itau Unibanco Holding Sa Pn Adr (NYSE:ITUB) was reduced too.